Cargando…
A Case of Success With Immunotherapy After Changing the Therapeutics Strategy in Non-small Cell Lung Cancer
Immune checkpoint inhibitors (ICI) have already shown benefit with higher response and survival rates when compared to standard chemotherapy in advanced non-small cell lung cancer (NSCLC). Although there is evidence that radiation and immunotherapy offer good response rates without additional toxici...
Autores principales: | Machado, Bárbara, Soares de Pinho, Inês, Aranha, Ana Rita, Malyarchuck, Viktor, Godinho, Joana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679959/ https://www.ncbi.nlm.nih.gov/pubmed/38021550 http://dx.doi.org/10.7759/cureus.47874 |
Ejemplares similares
-
Does the Combined Use of Aspirin and Immunotherapy Result in Better Outcomes in Non-Small Cell Lung Cancer Than Immunotherapy Alone?
por: Aiad, Mina, et al.
Publicado: (2022) -
Radiation-Associated Angiosarcoma as a Presentation of Disease Progression in a Patient on Immunotherapy for Metastatic Non-small Cell Lung Cancer
por: Tan, Hannah, et al.
Publicado: (2023) -
Current and novel therapeutic strategies for optimizing immunotherapy outcomes in advanced non-small cell lung cancer
por: Martin, Claudio, et al.
Publicado: (2022) -
Comparison of Pneumonitis Rates and Severity in Patients With Lung Cancer Treated by Immunotherapy, Radiotherapy, and Immunoradiotherapy
por: Aiad, Mina, et al.
Publicado: (2022) -
The Successful Treatment of a Case of Prostate Cancer With Brain Metastasis at Diagnosis
por: Vasques, Ana, et al.
Publicado: (2023)